Valuation : Optiscan Imaging Limited

Market Cap 157M 113M 97.23M 91.45M 83.48M 156M 10.69B 1.08B 419M 5.48B 425M 415M 17.44B P/E 2025
-14.5x
P/E 2026 -17.1x
Enterprise Value 144M 104M 89.15M 83.85M 76.54M 143M 9.8B 994M 384M 5.02B 389M 381M 15.99B EV / Sales 2025
23.8x
EV / Sales 2026 31.1x
Free-Float
36.32%
Yield 2025 *
-
Yield 2026 -
Manager TitleAgeSince
Chief Executive Officer - 2021-12-12
Director of Finance/CFO - 2025-03-30
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 2021-02-09
Chairman - 2021-04-18
Director/Board Member - 2021-05-05
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 113M
-1.23%+1.59%-24.82%-0.70% 13.22B
+3.57%-0.71%+14.55%+20.44% 4.23B
+3.07%+6.66%-35.60%-52.77% 1.27B
-1.10%-2.89%-37.11%-40.81% 1.14B
-3.63%-4.16%+15.92%+72.60% 1.07B
+1.26%+0.92% - - 1.03B
+0.44%-2.25%-36.93% - 1.02B
+3.52%-3.08%+30.09%+107.95% 503M
+0.34%+1.01%+67.32% - 300M
Average +0.62%-1.24%-0.82%+17.78% 2.64B
Weighted average by Cap. +0.05%+0.22%-14.92%+4.45%

Financials

2025 2026
Net sales 3.72M 2.69M 2.31M 2.17M 1.98M 3.71M 254M 25.78M 9.97M 130M 10.1M 9.87M 415M 3.61M 2.61M 2.24M 2.11M 1.93M 3.6M 247M 25.01M 9.67M 126M 9.79M 9.58M 402M
Net income -6.31M -4.56M -3.92M -3.69M -3.36M -6.29M -431M -43.69M -16.89M -221M -17.11M -16.74M -703M -6.99M -5.04M -4.34M -4.08M -3.72M -6.96M -477M -48.36M -18.69M -244M -18.94M -18.52M -778M
Net Debt -3.07M -2.22M -1.91M -1.79M -1.64M -3.06M -210M -21.26M -8.22M -107M -8.32M -8.14M -342M -13.01M -9.39M -8.07M -7.59M -6.93M -12.97M -888M -90.04M -34.81M -455M -35.26M -34.49M -1.45B
Logo Optiscan Imaging Limited
Optiscan Imaging Limited is a commercial stage medical technology company. It creates a suite of digital pathology and precision surgery hardware and software solutions that enable live optical biopsy for life sciences, diagnostic and surgical applications. It is engaged in development, manufacturing, and commercialization of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. Its technology enables real-time, non-destructive, 3D, in-vivo digital imaging at the single-cell level. Its products include InVue, InForm, InVivage, ViewnVivo and InSpecta. ViewnVivo offers single-cell level live imaging, providing biological system insights and enabling users to see life connected. Developed with its patented confocal imaging technology, ViewnVivo is a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging in the palm of your hand. InVivage is an intra-oral digital endomicroscope.
Employees
9
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!